Emerging research is raising new concerns about the effects of these drugs on muscle and bone health
The details: Trevogrumab was developed to treat muscle loss linked to immobility or aging, while garetosmab was created as a treatment for a rare disease where muscle tissue is replaced by bone (called fibrodysplasia ossificans progressiva)
This is what patients are hearing, so its a really tough disinformation battle, she said
For example, Rybelsus (semaglutide tablets), the first oral GLP-1 approved for type 2 diabetes, has demonstrated meaningful weight loss in clinical studies, although it currently requires strict administration guidelines (empty stomach, limited fluid intake before and after dosing)
If you can already get a GLP-1 covered through your regular Part D benefit for another reason, such as type 2 diabetes, you would receive it that way instead and arent eligible through the Bridge
When your weight concerns connect to hormonal changes, menstrual health, fertility, or pregnancy planning, an OBGYN brings added insight
